# Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

> **NCT06474091** · — · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT06474091
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-05-08
- **Primary completion:** 2029-05-08
- **Final completion:** 2029-05-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474091, "Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06474091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*